All Stories

  1. Adjuvant Dapagliflozin in Kidney Transplant Recipients with Diabetes and Heart Failure—An Observational Exploratory Study
  2. Managing peritoneal dialysis catheter after kidney transplant
  3. Real-World Outcomes of SGLT2 Inhibitors in Kidney Transplant Recipients with Post-Transplant Diabetes Mellitus: An Effectiveness and Safety Analysis
  4. Living Kidney Donor Perceptions About Organ Donation: Who are They, and How Do They Feel About the Process?
  5. Psychological Outcomes in a Cohort of Portuguese Living Kidney Donors
  6. Insights Into Peritoneal Dialysis Outcomes: An Approach Using Competing Risks Analysis
  7. Preoperative mapping and multidisciplinary team are the key to success of arteriovenous access for hemodialysis
  8. Agonistas do Receptor de Peptídeo Semelhante ao Glucagon-1 em Transplantados Renais - Estudo Retrospectivo de um Centro Hospitalar
  9. Glucagon-like Peptide-1 Receptor Agonists in Kidney Transplant Recipients – A Retrospective Single Center Study
  10. Comunicação na Prática Clínica, a Perspetiva dos Doentes com Cancro: Tradução do Questionário PACE (Patient Assessment Of Cancer Communication Experiences) para Português
  11. Predict mortality in elderly ESKD patients
  12. Demographic, clinical characteristics and cardiovascular disease burden in a Portuguese cohort of older chronic kidney disease patients
  13. Adenovirus infection—A rare cause of interstitial nephritis in kidney transplant
  14. The association between 25(OH)D levels, frailty status and obesity indices in older adults
  15. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning?
  16. Psychopathological dimensions in subjects with hereditary ATTR V30M amyloidosis and their relation with life events due to the disease
  17. Life paths of patients with transthyretin-related familial amyloid polyneuropathy Val30Met: a descriptive study
  18. ESPEN diagnostic criteria for malnutrition – A validation study in hospitalized patients
  19. Impact on mid-term kidney graft outcomes of pretransplant anti-HLA antibodies detected by solid-phase assays: Do donor-specific antibodies tell the whole story?
  20. Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study
  21. End-stage renal disease versus death in a Portuguese cohort of elderly patients: an approach using competing event analysis
  22. Comparison of Jamar and Bodygrip Dynamometers for Handgrip Strength Measurement
  23. Triceps skinfold compressibility in hospitalized patients
  24. Incorporating Scoring Risk Models for Care Planning of the Elderly with Chronic Kidney Disease
  25. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation
  26. Effects of Posture and Body Mass Index on Body Girth Assessment
  27. Financial impact of sarcopenia on hospitalization costs
  28. Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments
  29. Sarcopenia and length of hospital stay
  30. Sarcopenia among hospitalized patients – A cross-sectional study
  31. A triple-biomarker approach for the detection of delayed graft function after kidney transplantation using serum creatinine, cystatin C, and malondialdehyde
  32. Impact ofde novodonor-specific anti-HLA antibodies on grafts outcomes in simultaneous pancreas-kidney transplantation
  33. Usefulness of Six Diagnostic and Screening Measures for Undernutrition in Predicting Length of Hospital Stay: A Comparative Analysis
  34. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation
  35. The effect of delayed graft function on graft and patient survival in kidney transplantation: an approach using competing events analysis
  36. Leptin and Adiponectin During the First Week After Kidney Transplantation: Biomarkers of Graft Dysfunction?
  37. Health-related quality of life may improve after transplantation in pancreas-kidney recipients
  38. Familial Amyloid Polyneuropathy treatment with Tafamidis – evaluation of one- and two-year treatment in Porto, Portugal
  39. Comparative analysis of undernutrition screening and diagnostic tools as predictors of hospitalisation costs
  40. Handgrip strength measurement as a predictor of hospitalization costs
  41. Adipokines in Peritoneal Dialysis: Relevant Clinical Impact According to Body Composition
  42. Handgrip strength cutoff values for undernutrition screening at hospital admission
  43. Oxidative Stress in Kidney Transplantation
  44. Pancreatic autoantibodies after pancreas-kidney transplantation - do they matter?
  45. Posttransplant Allosensitization in Low Immunological Risk Kidney and Kidney-Pancreas Graft Recipients
  46. Handgrip Strength and Associated Factors in Hospitalized Patients
  47. Hand length as an alternative measurement of height
  48. Kidney Transplantation in Type 2 Diabetic Patients: A Matched Survival Analysis
  49. Cardiovascular Risk Factors and Events in Pancreas-Kidney Transplants
  50. Noncutaneous Neoplasms After Kidney Transplantation: Analysis at Single Center
  51. Pregnancy After Kidney Transplantation: Graft, Mother, and Newborn Complications
  52. A Comparison Between Serum Creatinine and Cystatin C-Based Equations for Estimation of Graft Function
  53. Advantages of Kidney Transplant Precocity in Graft Long-Term Survival
  54. Hyperuricemia in Adult Renal Allograft Recipients: Prevalence and Predictors
  55. Over Ten-Year Kidney Graft Survival Determinants
  56. First-Year Renal Function Predicts Long-Term Renal Allograft Loss
  57. Impact of Pediatric Kidney Transplantation on Long-Term Professional and Social Outcomes
  58. Steroid Withdrawal in Simultaneous Pancreas-Kidney Transplantation: A 7-Year Report
  59. Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M
  60. Impact Assessment in Living Kidney Donation: Psychosocial Aspects in the Donor
  61. Long-term treatment of anemia with recombinant human erythropoietin in familial amyloidosis TTR V30M
  62. Low Erythropoietin Production in Familial Amyloidosis TTR V30M Is Not Related with Renal Congophilic Amyloid Deposition
  63. The Influence of HLA Mismatches and Immunosuppression on Kidney Graft Survival: An Analysis of More Than 1300 Patients
  64. Peritoneal Membrane Evaluation in Routine Clinical Practice
  65. Liver transplantation and anemia in familial amyloidosis ATTR V30M
  66. Impact of Hepatitis C Virus on Renal Transplantation: Association With Poor Survival
  67. Renal Transplantation in Patients Over 60 Years of Age: A Single-Center Experience
  68. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation
  69. Immunosuppression With Antithymocyte Globulin in Renal Transplantation: Better Long-Term Graft Survival
  70. Impact of Homocysteinemia on Long-Term Renal Transplant Survival
  71. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry
  72. Kidney and anemia in familial amyloidosis type I
  73. End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors
  74. Kinetic modeling studies of ethylene polymerization reactions using supported chromium catalysts
  75. Homocysteine levels in pediatric renal transplant recipients
  76. Lipoprotein(A) in renal transplant recipients
  77. Hyperhomocysteinemia in renal transplantation: preliminary results
  78. Therapy of post-renal transplantation hyperlipidaemia: comparative study with simvastatin and fish oil